Login / Signup

Bilateral one-stage single-port sympathicotomy in primary focal hyperhidrosis, a prospective cohort study: treat earlier?

Michiel KuijpersGwen PeetersPetra W HarmsWobbe BoumaMike J DeJongsteMassimo A MarianiTheo J Klinkenberg
Published in: Journal of cardiothoracic surgery (2021)
BOSS is safe, effective, and offers a long-term curative solution in the treatment of PFH. Especially in the palmar PFH subgroup, R3 BOSS treatment results compare favorably to the treatment results of non-curative alternatives published in the current literature. Therefore, R3 BOSS should be offered to all patients with severe PFH, reporting insufficient benefit of treatment options such as oral and/or local agents.
Keyphrases
  • randomized controlled trial
  • clinical trial
  • rectal cancer
  • early onset
  • combination therapy
  • minimally invasive
  • study protocol
  • double blind